Four proven approaches stabilizing clinical operations help health systems improve staffing stability and care delivery amid workforce constraints.

With various challenges impacting the clinical supply chain, existing models are no longer fit-for-purpose and need to adapt.

T Biosciences, an immunotherapy company changing the future of treatment for solid tumors and other immune-mediated diseases, today announced the appointment of Rebeca Villarreal-Barragan, MBA, as ...

In today’s ACT Brief, we highlight how Bayesian methods are gaining operational traction, a major patient advocacy merger is streamlining clinical trial access, and machine learning is reshaping trial ...

Supply chain executives who embrace change will best position their organizations for the future of supply chain optimization ...

As clinical development grows more complex, sponsors are rethinking how outsourcing models, technology, and partnerships align to support both speed and sustainability. The shift toward hybrid models, ...

Artificial intelligence will radically transform the healthcare industry in the coming years. As AI and machine learning capabilities advance, new emerging applications promise to enhance clinical ...

Ascension, which operates 140 hospitals across 19 states and Washington, D.C., said it’s working with Mandiant, a Google subsidiary and cybersecurity company, to assist with the investigation and ...

Hospitals and health systems across the U.S. are making room in their C-suites for a new physician- and nurse-focused role: chief clinical operations officer. Chief medical officers and chief nursing ...

The Department is delighted to announce a new liaison who will work with our clinical leadership team. Libby Bollier, MSHA, will serve as Inpatient Medical Services Manager with UAB Medicine to ...

The clinical operations and trial management community is buzzing with anticipation as the most influential leaders in the field prepare to convene at the Fierce Clinical Summit set for September ...

Curebase, a San Francisco-based clinical trial company, has let go of an undetermined number of employees in a pivot away from decentralized and hybrid clinical trials to focus on software products.